Atlas Trials

A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

Clinical trial NCT03616132 · UNKNOWN

Trial details

NCT number
NCT03616132
Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Single Coronary Vessel Disease
Start date
2018-03-28
Primary completion
2019-03-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.